AI IntelligenceJun 27, 2026Primary Market
Article
Vance AI · $90M · Series A
Vance AI, a biotech AI startup, closed a Series A round. The company uses machine learning for drug discovery, accelerating the development of new therapies.
Data Cube AI EditorialSource: Crunchbase News
01
Source Brief
Vance AI, a biotech AI startup, closed a Series A round. The company uses machine learning for drug discovery, accelerating the development of new therapies.
02